Simultaneous inhibition of IGF-IR and InsR may provide superior antitumor efficacy compared with targeting IGF-IR alone
These variations may reduce GLP-1 secretion in the gut or make the pancreas less responsive to its signals
While Ozempic and other GLP-1 receptor agonists can help patients lose weight, they work best in conjunction with healthy lifestyle changes
*Correspondence: Yi Zhang, [email protected]
Evaluate biosimilars for injectables (liraglutide, dulaglutide, semaglutide) using similarity studies for quality, safety, immunogenicity, and sometimes clinical trials.[11] Monitor post-marketing safety, especially when many brands enter the market in a short time.[6] When done well, this approach gives India the best of both worlds: lower prices through Indian manufacturing, and safety through strong regulation